Dominica vs Maldives: HIV/AIDS deaths averted by antiretroviral therapy
Dominica
6.73 deaths
in 2024
Maldives
2.78 deaths
in 2024
Dominica rank
155th
Maldives rank
157th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Dominica
- Maldives
How they compare
Dominica currently reports 6.73 deaths against 2.78 deaths in Maldives, a difference of 3.95 deaths.
That makes Dominica's figure about 2.4 times Maldives's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Maldives ahead.
Dominica ranks 155th and Maldives ranks 157th of 157 countries.
Dominica has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Dominica | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 2.35 deaths | 0.2266 deaths | 2.12 deaths | Dominica |
| 2010s | 4.86 deaths | 1.11 deaths | 3.75 deaths | Dominica |
| 2020s | 6.02 deaths | 2.3 deaths | 3.72 deaths | Dominica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Dominica or Maldives?
- Dominica, at 6.73 deaths against 2.78 deaths in Maldives as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Dominica and Maldives?
- 3.95 deaths, with Dominica ahead.
- How many years of comparable data are there for Dominica and Maldives?
- 35 years are reported by both, from 1990 to 2024.
- How do Dominica and Maldives rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Dominica ranks 155th and Maldives ranks 157th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.